NPI: 1558325704 · RICHMOND, VA 23225 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,198 | $306K |
| 2019 | 22,397 | $451K |
| 2020 | 22,316 | $949K |
| 2021 | 24,697 | $810K |
| 2022 | 14,029 | $519K |
| 2023 | 13,169 | $807K |
| 2024 | 3,887 | $197K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 47,497 | 2,673 | $2.54M |
| 90945 | 13,950 | 507 | $1.29M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 22,892 | 1,876 | $148K |
| A4657 | Syringe, with or without needle, each | 5,792 | 1,676 | $23K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 172 | 119 | $12K |
| J1756 | Injection, iron sucrose, 1 mg | 6,018 | 1,511 | $11K |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,025 | 910 | $8K |
| 90674 | 141 | 105 | $677.80 | |
| 83970 | 1,584 | 979 | $396.10 | |
| 82728 | 1,354 | 857 | $212.69 | |
| 83550 | 1,340 | 840 | $136.27 | |
| 83540 | 1,352 | 853 | $100.98 | |
| G0008 | Administration of influenza virus vaccine | 92 | 67 | $69.03 |
| 85048 | 1,557 | 1,007 | $68.44 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 250 | 136 | $65.53 |
| 0012A | 15 | 12 | $56.78 | |
| 85041 | 1,577 | 1,020 | $53.95 | |
| 0011A | 30 | 21 | $35.12 | |
| 82108 | 55 | 36 | $1.33 |